Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà
MedNavigator.ru - Ïîèñê è ïîäáîð ëå÷åíèÿ â Ðîññèè è çà ðóáåæîì

Âåðíóòüñÿ   Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà > Ôîðóìû âðà÷åáíûõ êîíñóëüòàöèé > Ýíäîêðèíîëîãèÿ > Äèàáåò

Çàêðûòàÿ òåìà
 
Îïöèè òåìû Ïîèñê â ýòîé òåìå Îïöèè ïðîñìîòðà
  #16  
Ñòàðûé 02.08.2017, 20:06
camelot camelot âíå ôîðóìà ÂÐÀ×
Êàíäèäàò â âåòåðàíû ôîðóìà
      
 
Ðåãèñòðàöèÿ: 28.08.2010
Ãîðîä: ×åëÿáèíñê
Ñîîáùåíèé: 1,628
Ñêàçàë(à) ñïàñèáî: 171
Ïîáëàãîäàðèëè 477 ðàç(à) çà 471 ñîîáùåíèé
camelot ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcamelot ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcamelot ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcamelot ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcamelot ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcamelot ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcamelot ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcamelot ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcamelot ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcamelot ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcamelot ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ãàëèíà Àôàíàñüåâíà ìåíÿ ïîïðàâèò åñëè ÷òî, íî Âû ñäåëàëè èç âïîëíå õîðîøî ïîääàþùåéñÿ ëå÷åíèþ áîëÿ÷êè ÷òî-òî î÷åíü ñëîæíîå, îñîáåííî óìèëÿþò åæåäíåâíûå êàïåëüíèöû ñ ôèçðàñòâîðîì. Âàñ êîíñóëüòèðóþò âðà÷è, êîòîðûå õîðîøî ïîìíÿò êàê ðàäîâàëèñü ïàöèåíòû êîãäà "íþõàòåëüíûé" àäèóðåêðèí ñìåíèëñÿ íà óäîáíûå òàáëåòêè ìèíèðèí. Ïðè÷èíà
Öèòàòà:
òàê êàê ÷åðåç æåëóäîê íå ëþáëþ ïèòü, ñëèøêîì ìíîãî çàìîðî÷åê ïî ïîâîäó ïðèåìà òàáëåòîê ÷åðåç æåëóäîê
íå êàæåòñÿ ìíå óáåäèòåëüíîé, ÷òî-òî Âû íå äîãîâàðèâàåòå.
  #17  
Ñòàðûé 02.08.2017, 20:09
Stone14 Stone14 âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 01.08.2017
Ãîðîä: Ïîäîëüñê
Ñîîáùåíèé: 13
Stone14 *
Öèòàòà:
Ñîîáùåíèå îò Melnichenko Ïîñìîòðåòü ñîîáùåíèå
Ðàöïðåäëîæåíèÿ ( ðàöóõà ) òèïîâàÿ îñîáåííîñòü ðîññèéñêîãî ïàöèåíòà.
Äåëî â òîì , ÷òî ÃÈÏÎÍÀÒÐÈÅÌÈß êðàéíå îïàñíàÿ âåùü è îíàÿ ãîâîðèò î íåïðîðöèîíàëüíî âûñîêîì ñîäåðæàíèè âîäû â ïëàçìå- à òàêîå ìîæíî ïîëó÷èòü òîëüêî ÈÇÁÛÒÊÎÌ äåñìîïðåññèíà.
Îòñþäà âîïðîñ - à áûë ëè íåñàõàðíûé äèàáåò ( êñòàòè, ïèøåòñÿ ñëèòíî ), íå ïðèíÿëè ëè çà íåãî îøèáî÷íî äèïñîãåííóþ ïîëèóðèþ èëè êàêèå -òî äðóãèå çàáîëåâàíèÿ.
Êàêóþ ðîëü èãðàåò íåêîððåêòíîå ââåäåíèå ïðåïàðàòà - íå çíàþ.  íàó÷íîé ëèòåðàòóðå íå âñòðå÷àëàñü ñ îïèñàíèåì ïîäîáíîãî ñïîñîáà ââåäåíèÿ è åãî îïàñíîñòåé.
Äà ÿ òîæå òàêîãî ìíåíèå áûë è âðà÷è, íî åñòü îäíà çàãâîñòêà â òîì, ÷òî íàòðèé è õëîð ñ ìî÷îé âûâîäèòñÿ â èçáûòêå 284.00 ììîëü/ë íàòðèÿ â ìî÷å ïðè íîðìå âûâåäåíèå íàòðèÿ 40.00-220.00 ììîëü/ë, ïîëó÷àåòñÿ, ÷òî íàòðèÿ âûâîäèòñÿ ñëèøêîì ìíîãî, à çàìåùàåòñÿ ìåíüøå, ÷åì âûâîäèòñÿ, ïëàçìà ðàçáàâëÿåòñÿ è íàñòóïàåò ãèïîíàòðèìèÿ. À ðàíüøå êàê ÿ ïîíèìàþ îí íîðìàëüíî âûäåëÿëñÿ íå ïðåâûøàë íîðìó â ìî÷å , êîãäà ÿ ïðèíèìàë ìèíèðèí, çàíèìàëñÿ ñïîðòîì, ðàáîòîé, ïðè ÷åì ñïîðòîì äî èçíåìîæåíèÿ áûâàëî çàíèìàëñÿ è âñå ðàâíî ãèïîíàòðèìèè íå âîçíèêàëî, õîòü è óæàñíî ïîòåë îò ñïîðòèâíûõ ôèç íàãðóçîê è ìíîãî ïèë, îò ýòîãî, à âîò ïîä êîíåö çèìû 2017, íà÷àëàñü ãèïîíàòðèìèÿ è â ìî÷å îáíàðóæèëîñü èçáûòî÷íîå âûâåäåíèå íàòðèÿ. Ïðî äðóãèå çàáîëåâàíèÿ âðà÷è íè÷åãî íå ãîâîðèëè, òîëüêî ñêàçàëè åñëè ìèíèðèí ïåðåíîñèøü íîðìàëüíî, íàïèòüñÿ âîäû ìîæåøü ïðè óïîòðåáëåíèå ìèíèðèíà, òàê êàê âîäà çàäåðæèâàåòñÿ è íå ïðèõîäèòüñÿ áîëüøå ìíîãî ïèòü, òî äðóãèå çàáîëåâàíèÿ îòêëîíèëè.
  #18  
Ñòàðûé 02.08.2017, 20:18
Stone14 Stone14 âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 01.08.2017
Ãîðîä: Ïîäîëüñê
Ñîîáùåíèé: 13
Stone14 *
Öèòàòà:
Ñîîáùåíèå îò camelot Ïîñìîòðåòü ñîîáùåíèå
Ãàëèíà Àôàíàñüåâíà ìåíÿ ïîïðàâèò åñëè ÷òî, íî Âû ñäåëàëè èç âïîëíå õîðîøî ïîääàþùåéñÿ ëå÷åíèþ áîëÿ÷êè ÷òî-òî î÷åíü ñëîæíîå, îñîáåííî óìèëÿþò åæåäíåâíûå êàïåëüíèöû ñ ôèçðàñòâîðîì. Âàñ êîíñóëüòèðóþò âðà÷è, êîòîðûå õîðîøî ïîìíÿò êàê ðàäîâàëèñü ïàöèåíòû êîãäà "íþõàòåëüíûé" àäèóðåêðèí ñìåíèëñÿ íà óäîáíûå òàáëåòêè ìèíèðèí. Ïðè÷èíà íå êàæåòñÿ ìíå óáåäèòåëüíîé, ÷òî-òî Âû íå äîãîâàðèâàåòå.
ß îïå÷àòàëñÿ íåìíîãî, ÷åðåç æåëóäîê òàáëåòêè ïëîõî óñâàèâàþòñÿ, ÷åðåç íîñ ëó÷øå è ýôôåêò ëó÷øå ÷åðåç íîñ, à ýòî ýêîíîìèÿ, òàáëåòêè ñòîÿò 2500 ðóáëåé çà 1 ôëàêîí, à ìíå íóæíî èõ 1-2 ôëàêîíà â ìåñÿö, ìèíèðèí ñåé÷àñ íå âûäàþò áîëüíûì, òàê êàê áûëè ñîêðàùåíèÿ è òåïåðü ïðåïàðàò âûäàþò òîëüêî òåì ó êîãî åñòü íåñàõàðíûé äèàáåò è èíâàëèäíîñòü 3 ñòåïåíè. È òî ìîãóò íàñòîÿòü íà ïðåïàðàòå Íàòèâà, à íå Ìèíèðèíå, à Íàòèâà íå äàë õîðîøèõ îòçûâîâ ó áîëüíûõ.
  #19  
Ñòàðûé 02.08.2017, 20:22
Stone14 Stone14 âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 01.08.2017
Ãîðîä: Ïîäîëüñê
Ñîîáùåíèé: 13
Stone14 *
À ñëîæíîñòè â íåñàõàðíîì äèàáåòå íåòó, åñëè îí êîìïåíñèðóåòñÿ òàáëåòêàìè è ñëîæíîñòåé íå âîçíèêàëî äî êîíöà çèìû 2017 ã , ïîêà íàòðèé íå ñòàë âûâîäèòñÿ ñ ìî÷îé áîëüøå íîðìû, à îò ýòîãî â ñâîþ î÷åðåäü ñòàëà ãèïîíàòðèìèÿ, à ôèç ðàñòâîð ïîìîãàåò îðãàíèçìó ïîäíÿòü íàòðèé, âåäü ïðè ãèïîíàòðèìèè ÷àñòî àïïåòèòà âîîáùå íåòó
  #20  
Ñòàðûé 02.08.2017, 20:26
camelot camelot âíå ôîðóìà ÂÐÀ×
Êàíäèäàò â âåòåðàíû ôîðóìà
      
 
Ðåãèñòðàöèÿ: 28.08.2010
Ãîðîä: ×åëÿáèíñê
Ñîîáùåíèé: 1,628
Ñêàçàë(à) ñïàñèáî: 171
Ïîáëàãîäàðèëè 477 ðàç(à) çà 471 ñîîáùåíèé
camelot ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcamelot ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcamelot ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcamelot ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcamelot ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcamelot ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcamelot ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcamelot ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcamelot ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcamelot ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcamelot ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ïîíÿòíî, íî Âû íå ñìîæåòå ïîäîáðàòü äîçèðîâêó-à åñëè íàñìîðê? ÷èõíóë ïîñëå "íþõà", åùå êàêèå íåâåäîìûå ìîìåíòû-âñîñàëîñü áîëüøå èëè ìåíüøå?
  #21  
Ñòàðûé 02.08.2017, 20:42
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,606
Ïîáëàãîäàðèëè 33,348 ðàç(à) çà 31,695 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Íàâåðíîå, Âàì èìååò ñìûñë ïî÷èòàòü î ãèïîíàòèåìèè, êîòîðàÿ ìîæåò ïðèâîäèòü ê ñóäîðîãàì, îòåêó ãîëîâíîãî ìîçãà è êîìàòîçíîìó ñîñòîÿíèþ èç-çà ïåðåäîçèðîâêè ìèíèðèíà, òîãäà áûòü ìîæåò Âû çàäóìàåòåñü î òîì, ÷òî Âû äåëàåòå è êàêîìó ðèñêó ñåáÿ ïîäâåðãàåòå?

Pharmacotherapy. 1996 Jan-Feb;16(1):66-74.
Intranasal desmopressin-induced hyponatremia.
Williford SL, Bernstein SA.


Desmopressin is a commonly used, well-tolerated agent for the treatment of primary nocturnal enuresis and central diabetes insipidus. Intranasal desmopressin provides symptomatic relief with few serious complications. A 29-year-old woman with a long history of primary nocturnal enuresis began treatment with intranasal desmopressin. Although the enuresis ceased, she developed throbbing headaches, nausea, vomiting, paresthesia, lethargy, fatigue, and altered mental status over the next 7 days. When she came to the emergency room her sodium concentration was 127 mmol/L. The history of desmopressin use was not obtained at that time. She was treated with intravenous fluids and discharged. The symptoms returned and worsened over the next 4 days, and she returned to the emergency room stuporous. A repeat sodium was 124 mmol/L, and she was admitted. The history of desmopressin use was still not available. Medical evaluations included computerized tomography, lumbar puncture, complete blood counts, serum chemistries, and serologies. The next morning the woman was improved and informed clinicians of her desmopressin use. Without other causes for the hyponatremia, she was diagnosed with the syndrome of inappropriate antidiuretic hormone, presumably caused by desmopressin. Within 24 hours of fluid restriction and cessation of desmopressin, her symptoms and hyponatremia resolved. A review of the literature found 11 children and 2 adults in whom intranasal desmopressin was associated with hyponatremia, all of whom experienced seizures or altered mental status. Our patient illustrates the importance of early recognition and treatment of hyponatremia before the onset of seizures. When vague symptoms develop during desmopressin therapy, hyponatremia must be considered as part of the differential diagnosis. It may also be prudent to screen for electrolyte abnormalities in patients taking this agent to prevent serious iatrogenic complications.
______________________________________

J Clin Pharmacol. 2001 May;41(5):582-4.
Coma and seizures due to severe hyponatremia and water intoxication in an adult with intranasal desmopressin therapy for nocturnal enuresis.
Odeh M, Oliven A.


Desmopressin, a synthetic analogue of the antidiuretic hormone, is an effective medication for primary nocturnal enuresis for both children and adults. Its safety is well established. Although it has a favorable side effect profile, because of its pharmacological effect, intranasal desmopressin can rarely induce water intoxication with profound hyponatremia if given without adequate restriction of water intake. The authors describe an adult patient with water intoxication and severe hyponatremia accompanied by loss of consciousness and seizures after 2-day intranasal administration of desmopressin. The present and the previously reported cases emphasize the need for greater awareness of the development of this serious and potentiallyfatal complication. In addition, to adjust the drug to the lowest required dosage, adequate restriction of water intake is recommended, and serum levels of sodium should be measured periodically to allow for early detection of water intoxication and hyponatremia.
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
  #22  
Ñòàðûé 02.08.2017, 20:47
Stone14 Stone14 âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 01.08.2017
Ãîðîä: Ïîäîëüñê
Ñîîáùåíèé: 13
Stone14 *
Öèòàòà:
Ñîîáùåíèå îò camelot Ïîñìîòðåòü ñîîáùåíèå
Ïîíÿòíî, íî Âû íå ñìîæåòå ïîäîáðàòü äîçèðîâêó-à åñëè íàñìîðê? ÷èõíóë ïîñëå "íþõà", åùå êàêèå íåâåäîìûå ìîìåíòû-âñîñàëîñü áîëüøå èëè ìåíüøå?
ß äîëãî ñèäåë íà ôîðóìå ïî íåñàõàðíîìó äèàáåòó è ÷èòàÿ è îáùàÿñü ñ äðóãèìè ëþäüìè ó êîòîðûõ íåñàõàðíûé äèàáåò, óçíàë ìíîãî èíôîðìàöèè î òîì, ÷òî äîçèðîâêà ñêà÷åò ó ìíîãèõ ëþäåé ïðè îáû÷íîì ïðèåìå ìèíèðèíà. À îò ÷åãî îíà ìåíÿåòñÿ íå êîìó íå èçâåñòíî, íà êîãî òî ïîãîäà âëèÿåò, ñêà÷êè äàâëåíèÿ, íåñòàáèëüíàÿ ïîãîäà, òî ñîëíöå, òî äîæäü, ó êîãî òî ïîñòîÿííûå èçìåíåíèÿ äîçèðîâêè â òå÷åíèÿ âðåìåíè , òî â áîëüøóþ ñòîðîíó, òî â ìåíüøåþ. Ïî ñåáå ìîãó ñêàçàòü, ÷òî ëåòîì ÿ ñåáÿ ëó÷øå ÷óâñòâóþ è â òåïëóþ õîðîøóþ ïîãîäó ó ìåíÿ õîðîøåå ñîñòîÿíèå è óìåíüøåííàÿ äîçèðîâêà ìèíèðèíà è äàæå âîäû ëåòîì ÿ ïüþ ìåíüøå, ÷åì çèìîé, òàê ÷òî ìîãó ñêàçàòü äîçèðîâêà ïðåïàðàòà íå ó âñåõ ñòàáèëüíàÿ. À åñëè ó ìåíÿ íàñìîðê ÿ ïîëüçóþñü ñîñóäîñóæèâàþùèìè ïðåïàðàòàìè è ïðîìûâàíèåì íîñà è ñòàðàþñü íå ÷èõàòü è ÷èñòèòü íîñ ñ óòðà ïåðåä ïðèåìîì ìèíèðèíà). À â öåëîì êîíå÷íî, êîãäà íàñìîðê ïðåïàðàòà óõîäèò ïîáîëüøå.
  #23  
Ñòàðûé 02.08.2017, 20:55
Stone14 Stone14 âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 01.08.2017
Ãîðîä: Ïîäîëüñê
Ñîîáùåíèé: 13
Stone14 *
Öèòàòà:
Ñîîáùåíèå îò Dr.Vad Ïîñìîòðåòü ñîîáùåíèå
Íàâåðíîå, Âàì èìååò ñìûñë ïî÷èòàòü î ãèïîíàòèåìèè, êîòîðàÿ ìîæåò ïðèâîäèòü ê ñóäîðîãàì, îòåêó ãîëîâíîãî ìîçãà è êîìàòîçíîìó ñîñòîÿíèþ èç-çà ïåðåäîçèðîâêè ìèíèðèíà, òîãäà áûòü ìîæåò Âû çàäóìàåòåñü î òîì, ÷òî Âû äåëàåòå è êàêîìó ðèñêó ñåáÿ ïîäâåðãàåòå?

Pharmacotherapy. 1996 Jan-Feb;16(1):66-74.
Intranasal desmopressin-induced hyponatremia.
Williford SL, Bernstein SA.


Desmopressin is a commonly used, well-tolerated agent for the treatment of primary nocturnal enuresis and central diabetes insipidus. Intranasal desmopressin provides symptomatic relief with few serious complications. A 29-year-old woman with a long history of primary nocturnal enuresis began treatment with intranasal desmopressin. Although the enuresis ceased, she developed throbbing headaches, nausea, vomiting, paresthesia, lethargy, fatigue, and altered mental status over the next 7 days. When she came to the emergency room her sodium concentration was 127 mmol/L. The history of desmopressin use was not obtained at that time. She was treated with intravenous fluids and discharged. The symptoms returned and worsened over the next 4 days, and she returned to the emergency room stuporous. A repeat sodium was 124 mmol/L, and she was admitted. The history of desmopressin use was still not available. Medical evaluations included computerized tomography, lumbar puncture, complete blood counts, serum chemistries, and serologies. The next morning the woman was improved and informed clinicians of her desmopressin use. Without other causes for the hyponatremia, she was diagnosed with the syndrome of inappropriate antidiuretic hormone, presumably caused by desmopressin. Within 24 hours of fluid restriction and cessation of desmopressin, her symptoms and hyponatremia resolved. A review of the literature found 11 children and 2 adults in whom intranasal desmopressin was associated with hyponatremia, all of whom experienced seizures or altered mental status. Our patient illustrates the importance of early recognition and treatment of hyponatremia before the onset of seizures. When vague symptoms develop during desmopressin therapy, hyponatremia must be considered as part of the differential diagnosis. It may also be prudent to screen for electrolyte abnormalities in patients taking this agent to prevent serious iatrogenic complications.
______________________________________

J Clin Pharmacol. 2001 May;41(5):582-4.
Coma and seizures due to severe hyponatremia and water intoxication in an adult with intranasal desmopressin therapy for nocturnal enuresis.
Odeh M, Oliven A.


Desmopressin, a synthetic analogue of the antidiuretic hormone, is an effective medication for primary nocturnal enuresis for both children and adults. Its safety is well established. Although it has a favorable side effect profile, because of its pharmacological effect, intranasal desmopressin can rarely induce water intoxication with profound hyponatremia if given without adequate restriction of water intake. The authors describe an adult patient with water intoxication and severe hyponatremia accompanied by loss of consciousness and seizures after 2-day intranasal administration of desmopressin. The present and the previously reported cases emphasize the need for greater awareness of the development of this serious and potentiallyfatal complication. In addition, to adjust the drug to the lowest required dosage, adequate restriction of water intake is recommended, and serum levels of sodium should be measured periodically to allow for early detection of water intoxication and hyponatremia.

ß çíàþ ÷òî òàêîå ãèïîíàòðèìèÿ è çíàþ ðèñê è áîþñü ýòîãî, âîò è ñïðàøèâàþ ñîâåòà. Êàê ìíå äàâíî îáúÿñíÿëè, ÷òî íà âûñîêèé óðîâåíü ãîðìîíà â êðîâè îðãàíèçì íîðìàëüíî îòâå÷àåò, ïðîñòî â òóàëåò äîëãî íå áóäåò õîòåòüñÿ, çäåñü ãëàâíîå íå ïåðåáîðùèòü ñ âîäîé, ÷òî áû âîäû ìíîãî íå çàäåðæèâàëîñü â îðãàíèçìå, íó à âîäà è íå çàäåðæèâàåòñÿ ó ìåíÿ, âåñ ñòàáèëüíûé ó ìåíÿ ñ óòðà 83 êã íà äàííûé ìîìåíò, ÿ ïîñòîÿííî âçâåøèâàþñü. Ó ìåíÿ íå áûâàåò òàêîãî ÷òî áû âûïèë â ñóòêè 3 ëèòðà à âîäû âûøëî 500 ìë), ÿ åñëè 3 âûïèë, òî 2500-2700 èç ìåíÿ âûéäåò, îñòàâøàÿñÿ âîäà â îðãàíèçìå è ïèùà óéäåò â ýíåðãèþ äíåì è ïîò è äûõàíèå, ïëþñ íî÷ü äëèííàÿ âïåðåäè, à íî÷üþ ÿ íå ïüþ, à ñ óòðà âåñ, îïÿòü ñòàáèëüíûé, òàê êàê êàæäûé äåíü èëè ÷åðåç äåíü âçâåøèâàþñü
  #24  
Ñòàðûé 02.08.2017, 21:00
camelot camelot âíå ôîðóìà ÂÐÀ×
Êàíäèäàò â âåòåðàíû ôîðóìà
      
 
Ðåãèñòðàöèÿ: 28.08.2010
Ãîðîä: ×åëÿáèíñê
Ñîîáùåíèé: 1,628
Ñêàçàë(à) ñïàñèáî: 171
Ïîáëàãîäàðèëè 477 ðàç(à) çà 471 ñîîáùåíèé
camelot ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcamelot ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcamelot ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcamelot ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcamelot ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcamelot ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcamelot ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcamelot ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcamelot ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcamelot ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcamelot ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Îòñþäà âîïðîñ - à áûë ëè íåñàõàðíûé äèàáåò ( êñòàòè, ïèøåòñÿ ñëèòíî ), íå ïðèíÿëè ëè çà íåãî îøèáî÷íî äèïñîãåííóþ ïîëèóðèþ èëè êàêèå -òî äðóãèå çàáîëåâàíèÿ.
à â îñòàëüíîì ìû íå ìîæåì çàñòàâèòü Âàñ ïîëüçîâàòü ìèíèðèí òåì èëè èíûì ñïîñîáîì, íî öåíà ìîæåò áûòü âåñüìà âûñîêîé.
  #25  
Ñòàðûé 02.08.2017, 21:06
Àâàòàð äëÿ Melnichenko
Melnichenko Melnichenko âíå ôîðóìà
ÂÐÀ×
      
 
Ðåãèñòðàöèÿ: 26.07.2001
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 117,365
Ñêàçàë(à) ñïàñèáî: 26
Ïîáëàãîäàðèëè 33,649 ðàç(à) çà 32,723 ñîîáùåíèé
Melnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò Stone14 Ïîñìîòðåòü ñîîáùåíèå
Äà ÿ òîæå òàêîãî ìíåíèå áûë è âðà÷è, íî åñòü îäíà çàãâîñòêà â òîì, ÷òî íàòðèé è õëîð ñ ìî÷îé âûâîäèòñÿ â èçáûòêå 284.00 ììîëü/ë íàòðèÿ â ìî÷å ïðè íîðìå âûâåäåíèå íàòðèÿ 40.00-220.00 ììîëü/ë, ïîëó÷àåòñÿ, ÷òî íàòðèÿ âûâîäèòñÿ ñëèøêîì ìíîãî, à çàìåùàåòñÿ ìåíüøå, ÷åì âûâîäèòñÿ, ïëàçìà ðàçáàâëÿåòñÿ è íàñòóïàåò ãèïîíàòðèìèÿ. .
È ýòî ÿâíî íå çàñëóãà íåñàõàðíîãî äèàáåòà.
ÇàãâîçÄêà, äëÿ íà÷àëà , â òîì, ÷òî íåò îñíîâàíèé ñ÷èòàòü, ÷òî ó Âàñ ÅÑÒÜ íåñàõàðíûé äèàáåò.
Åùå ðàç - ÌÐÒ è âèäåí ëè íåéðîãèïîôèç.
Ñêàæèòå, Âû 10 ëåò ( èëè äàæå 11 ) ó÷èëèñü â øêîëå è äåëàåòå îøèáêè âåñìà ÷àñòî, Âû äàæå ñ îøèáêàìè ïèøåòå íàçâàíèå ñâîåé áîëåçíè- íà îñíîâàíèè êàêèõ äàííûõ Âû ïðåäïîëàãàëè, ÷òî Âàø ñàìîäåÿòåëüíîñòü âêóïå ñ ñèäåíèåì íà ôîðóìàõ äàñò Âàì çäîðîâüå ? Âåäü åñëè äàæå ãðàìîòíî ïèñàòü Âû íå ìîæåòå - ïî÷åìó äàìàåòå, ÷òî ìîæåòå ñåáÿ ëå÷èòü ?
__________________
Ã.À. Ìåëüíè÷åíêî
  #26  
Ñòàðûé 02.08.2017, 21:12
Stone14 Stone14 âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 01.08.2017
Ãîðîä: Ïîäîëüñê
Ñîîáùåíèé: 13
Stone14 *
Dr.vad ÿ ïåðåâåë òåêñò , ïðî÷èòàë îïûò àìåðèêàíöåâ ïðî èñïîëüçîâàíèå èíòðàíàçàëüíîãî ïðèìåíåíèÿ äåñïîïðåññèíà, íî íè÷åãî íîâîãî íå óçíàë äëÿ ñåáÿ, òàêèõ èñòîðèé ïîëíî íà ðîññèéñêîì ôîðóìå ïî íåñàõàðíîìó äèàáåòó îò áîëüíûõ íåñàõàðíûì äèàáåòîì è èõ ðàññêàçîâ î ïðèåìå òîãî èëè èíîãî ïðåïàðàòà è èõ ïîáî÷íûõ ýôôåêòîâ è ïðîáëåìàõ âñòðå÷àþùèõñÿ ïðè ëå÷åíèå ãîðìîíîì
  #27  
Ñòàðûé 02.08.2017, 21:14
Àâàòàð äëÿ Melnichenko
Melnichenko Melnichenko âíå ôîðóìà
ÂÐÀ×
      
 
Ðåãèñòðàöèÿ: 26.07.2001
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 117,365
Ñêàçàë(à) ñïàñèáî: 26
Ïîáëàãîäàðèëè 33,649 ðàç(à) çà 32,723 ñîîáùåíèé
Melnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò Stone14 Ïîñìîòðåòü ñîîáùåíèå
ß äîëãî ñèäåë íà ôîðóìå ïî íåñàõàðíîìó äèàáåòó è ÷èòàÿ è îáùàÿñü ñ äðóãèìè ëþäüìè ó êîòîðûõ íåñàõàðíûé äèàáåò, óçíàë ìíîãî èíôîðìàöèè î òîì, ÷òî äîçèðîâêà ñêà÷åò ó ìíîãèõ ëþäåé ïðè îáû÷íîì ïðèåìå ìèíèðèíà. À îò ÷åãî îíà ìåíÿåòñÿ íå êîìó íå èçâåñòíî, íà êîãî òî ïîãîäà âëèÿåò, ñêà÷êè äàâëåíèÿ, íåñòàáèëüíàÿ ïîãîäà, òî ñîëíöå, òî äîæäü, ó êîãî òî ïîñòîÿííûå èçìåíåíèÿ äîçèðîâêè â òå÷åíèÿ âðåìåíè , òî â áîëüøóþ ñòîðîíó, òî â ìåíüøåþ. Ïî ñåáå ìîãó ñêàçàòü, ÷òî ëåòîì ÿ ñåáÿ ëó÷øå ÷óâñòâóþ è â òåïëóþ õîðîøóþ ïîãîäó ó ìåíÿ õîðîøåå ñîñòîÿíèå è óìåíüøåííàÿ äîçèðîâêà ìèíèðèíà è äàæå âîäû ëåòîì ÿ ïüþ ìåíüøå, ÷åì çèìîé, òàê ÷òî ìîãó ñêàçàòü äîçèðîâêà ïðåïàðàòà íå ó âñåõ ñòàáèëüíàÿ. À åñëè ó ìåíÿ íàñìîðê ÿ ïîëüçóþñü ñîñóäîñóæèâàþùèìè ïðåïàðàòàìè è ïðîìûâàíèåì íîñà è ñòàðàþñü íå ÷èõàòü è ÷èñòèòü íîñ ñ óòðà ïåðåä ïðèåìîì ìèíèðèíà). À â öåëîì êîíå÷íî, êîãäà íàñìîðê ïðåïàðàòà óõîäèò ïîáîëüøå.
Ïðåäíàçíà÷åííûé äëÿ ïåðîðàëüíîãî ïðèåìà ìèíèðèí íå ñîçäàí äëÿ ââåäåíèÿ ÷åðåç íîñ.
Äîçèðîâêà ìèíèðèíà èìååò ñâîåé öåëüþ ñäåëàòü ñîöèàëüíî ïðèåìëåìûì ( è íå áîëåå òîãî ) ÷èñëî ìî÷åèñïóñêàíèé, è , åñ-ñíî , êîëåáëåòñÿ â çàâèñèìîñòè îò ïîòîîòäåëåíèÿ èëè âûõîäíûõ \ êàíèêóëÿðíûõ äíåé.
Ïîòåðÿ íàòðèÿ ñ ìî÷îé ðåãóëèðóåòñÿ àëüäîñòåðîíîì\ êîðòèçîëîì , è íå ÿâëÿåòñÿ îðèåíòèðîì ïðè ïðèíÿòèè ðåøåíèÿ î äîçå ìèíèðèíà.
"Ãîðå îò óìà" óæå íàïèñàíî... Ñåãîäíÿ íàäî ïèñàòü íîâóþ ïüåñó "êîìïüòåðíàÿ èíòîêñèêàöèÿ ó îáðàçîâàíùèíû".

Êîììåíòàðèè ê ñîîáùåíèþ:
Dr.Vad îäîáðèë(à):
__________________
Ã.À. Ìåëüíè÷åíêî
  #28  
Ñòàðûé 02.08.2017, 21:15
Àâàòàð äëÿ Melnichenko
Melnichenko Melnichenko âíå ôîðóìà
ÂÐÀ×
      
 
Ðåãèñòðàöèÿ: 26.07.2001
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 117,365
Ñêàçàë(à) ñïàñèáî: 26
Ïîáëàãîäàðèëè 33,649 ðàç(à) çà 32,723 ñîîáùåíèé
Melnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò Stone14 Ïîñìîòðåòü ñîîáùåíèå
Dr.vad ÿ ïåðåâåë òåêñò , ïðî÷èòàë îïûò àìåðèêàíöåâ ïðî èñïîëüçîâàíèå èíòðàíàçàëüíîãî ïðèìåíåíèÿ äåñïîïðåññèíà, íî íè÷åãî íîâîãî íå óçíàë äëÿ ñåáÿ, òàêèõ èñòîðèé ïîëíî íà ðîññèéñêîì ôîðóìå ïî íåñàõàðíîìó äèàáåòó îò áîëüíûõ íåñàõàðíûì äèàáåòîì è èõ ðàññêàçîâ î ïðèåìå òîãî èëè èíîãî ïðåïàðàòà è èõ ïîáî÷íûõ ýôôåêòîâ è ïðîáëåìàõ âñòðå÷àþùèõñÿ ïðè ëå÷åíèå ãîðìîíîì
ÏÐè ýòîì èñïîëüçîâàëñÿ ñïåöèàëüíî ñîçäàííûé äëÿ èíòðàíàçàëüíîãî ââåäåíèÿ ïðåïàðàò - Âû æå èñïîëüçóåòå ,âîçîæíî ,íå ïî ïîêàçàíèÿì , ñàìîïàëüíûé ïðåïàðàò. Íó äà âîëÿ Âàøà. Äàé Áîã èçáåæàòü îòåêà ìîçãà
__________________
Ã.À. Ìåëüíè÷åíêî
  #29  
Ñòàðûé 02.08.2017, 21:18
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,606
Ïîáëàãîäàðèëè 33,348 ðàç(à) çà 31,695 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Âû è íå ìîæåòå óçíàòü íè÷åãî íîâîãî, èáî Âàøà ïðîáëåìà èç-çà õðîíè÷åñêîé ïåðåäîçèðîâêè äåñìîïðåññèíà è åäèíñòâåííûé âûõîä - ïåðåõîäèòü íà íîðìàëüíûå ôîðìû ëåêàðñòâà ñ ïðåäñêàçóåìîé êèíåòèêîé, åñëè Âû äóìàåòå ÷òî ñýêîíîìèòå, òî ïîäóìàéòå âî ñêîëüêî âñòàíóò Âàøèì ðîäñòâåííèêàì Âàøè ïðîâîäû â ïîñëåäíèé ïóòü.
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Çàêðûòàÿ òåìà



Âàøè ïðàâà â ðàçäåëå
Âû íå ìîæåòå ñîçäàâàòü òåìû
Âû íå ìîæåòå îòâå÷àòü íà ñîîáùåíèÿ
Âû íå ìîæåòå ïðèêðåïëÿòü ôàéëû
Âû íå ìîæåòå ðåäàêòèðîâàòü ñîîáùåíèÿ

BB êîäû Âêë.
Ñìàéëû Âêë.
[IMG] êîä Âêë.
HTML êîä Âûêë.



×àñîâîé ïîÿñ GMT +3, âðåìÿ: 03:34.




Ðàáîòàåò íà vBulletin® âåðñèÿ 3.
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.